MedPath

Center for Research in Security Prices, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome

Phase 4
Completed
Conditions
Childhood Obstructive Sleep Apnea Syndrome (OSAS)
Interventions
First Posted Date
2008-01-28
Last Posted Date
2015-05-04
Lead Sponsor
University of Chicago
Target Recruit Count
24
Registration Number
NCT00603044
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme

Phase 2
Completed
Conditions
Glioblastoma Multiforme
Interventions
First Posted Date
2008-01-11
Last Posted Date
2021-03-30
Lead Sponsor
University of Chicago
Target Recruit Count
62
Registration Number
NCT00590681
Locations
🇺🇸

NorthShore University health system, Evanston, Illinois, United States

🇺🇸

The University of Chicago, Chicago, Illinois, United States

🇺🇸

University of Michigan, Ann Arbor, Michigan, United States

and more 2 locations

Intranasal Steroids and Oxymetazoline in Allergic Rhinitis

Phase 4
Completed
Conditions
Allergic Rhinitis
Interventions
First Posted Date
2008-01-02
Last Posted Date
2013-12-17
Lead Sponsor
University of Chicago
Target Recruit Count
64
Registration Number
NCT00584987
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers

Early Phase 1
Completed
Conditions
Solid Tumors
Interventions
First Posted Date
2007-12-31
Last Posted Date
2013-06-12
Lead Sponsor
University of Chicago
Target Recruit Count
23
Registration Number
NCT00583063
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

The Application of Neck Ultrasound in the Assessment of Peripherally Inserted Central Catheter (PICC) Tip Position

Not Applicable
Completed
Conditions
Peripherally Inserted Central Catheter Insertion Technique
Interventions
Other: Ultrasound inspection
First Posted Date
2007-11-30
Last Posted Date
2014-03-18
Lead Sponsor
University of Chicago
Target Recruit Count
300
Registration Number
NCT00565877
Locations
🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer

Not Applicable
Completed
Conditions
Pancreatic Cancer
Interventions
Procedure: Multiple needle
Procedure: Single needle
First Posted Date
2007-10-24
Last Posted Date
2015-12-21
Lead Sponsor
University of Chicago
Target Recruit Count
47
Registration Number
NCT00548626
Locations
🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer

Phase 2
Completed
Conditions
Carcinoma, Renal Cell
Interventions
First Posted Date
2007-09-14
Last Posted Date
2018-04-25
Lead Sponsor
University of Chicago
Target Recruit Count
60
Registration Number
NCT00529802
Locations
🇺🇸

Oncology/Hematology Associates, Peoria, Illinois, United States

🇺🇸

University of Chicago, Chicago, Illinois, United States

🇺🇸

Beth Israel Deaconess Med Ctr, Boston, Massachusetts, United States

and more 2 locations

Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation

Completed
Conditions
Bronchiolitis Obliterans Syndrome
First Posted Date
2007-09-12
Last Posted Date
2016-08-19
Lead Sponsor
University of Chicago
Target Recruit Count
10
Registration Number
NCT00528853
Locations
🇺🇸

The University of Chicago Medical Center, Chicago, Illinois, United States

Statins for the Early Treatment of Sepsis

Phase 2
Terminated
Conditions
Sepsis
Interventions
Drug: Identical-appearing placebo
First Posted Date
2007-09-12
Last Posted Date
2018-09-05
Lead Sponsor
University of Chicago
Target Recruit Count
68
Registration Number
NCT00528580
Locations
🇺🇸

The University of Chicago, Chicago, Illinois, United States

A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies

Phase 1
Completed
Conditions
Genital Neoplasms, Female
Interventions
Drug: CCI-779 (temsirolimus)
First Posted Date
2007-08-31
Last Posted Date
2013-09-05
Lead Sponsor
University of Chicago
Target Recruit Count
15
Registration Number
NCT00523432
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath